Dr. McCoy honored for extraordinary commitment and dedication to patients and the community
Roanoke, Virginia and
The Woodlands, Texas (May 19, 2014) – Blue Ridge Cancer
Care (BRCC), a practice in The US Oncology Network, is pleased to announce that medical oncologist,
Harry McCoy, M.D., was named both the local
and national winner of the prestigious Frist Humanitarian Physician Award. The
local recognition came from LewisGale Hospital Montgomery, while the national award
was received from the parent company of LewisGale Regional Health System, Hospital
Corporation of America (HCA).
The
42nd annual Frist Humanitarian National Awards are HCA’s highest
honor. Each year an employee, a volunteer and a physician are selected to
receive the award from local award winners around the country for demonstrating
extraordinary concern for the welfare and happiness of patients and their
communities. Dr. McCoy received the national physician award on April 28 in
Nashville at a special ceremony, along with a $10,000 donation to his favorite
charity. He chose to donate his award money to the Sojourn Center, an
organization dedicated to developing a hospice house and end of life center.
“We
could not be more proud, nor happy, that Dr. McCoy was
selected for this award,” said William Fintel, M.D., practice
president, BRCC. “He has been tireless throughout his career on behalf of his
patients and the entire community that he serves. Receiving the Frist
Humanitarian Award here in Virginia, and simultaneously the national award, is
an achievement that no one could deserve more. He is an accomplished physician,
a dedicated husband and father and a natural leader in our oncology community.
He places excellence in patient care at the top of his “to-do” list each
morning. We congratulate him and thank his fine family for their patience as he
continues to be an integral part of our cancer program and the very fabric of
southwest Virginia.”
Established
in 1971, the Frist Humanitarian Awards honor outstanding individuals for their
humanitarian and volunteer activities. The awards are given annually in
recognition of the caring spirit and philanthropic work of the late Dr. Thomas
Frist Sr., a founder of HCA. Employees, volunteers and medical staff members
who demonstrate commitment and dedication to providing outstanding care and
humanitarianism are selected from across the country, and honorees are
recognized at the local level. Three national recipients are then chosen from
more than 200 hospital-level honorees.
Dr.
McCoy has been in private practice serving patients in Virginia since 1992. He
joined Blue Ridge Cancer Care in 1999. A native of Norfolk, Virginia, he
received a B.A. in psychology from the University of Virginia. He then went on
to the University of Virginia’s Medical School and obtained his M.D. degree.
Dr. McCoy did his internship, residency and a four year fellowship in
hematology and oncology at the University of Florida. He is board certified in
medical oncology, hematology, and internal medicine, as well as hospice and
palliative care.
About Blue Ridge Cancer Care
For more
than 33 years, Blue Ridge Cancer Care (BRCC) has helped patients with cancer
and blood disorders get the most out of life. As a privately-owned practice of
18 physicians, BRCC serves patients in nine locations throughout Southwest
Virginia. The high-quality care provided at BRCC includes state-of-the-art
technologies and treatments delivered in a compassionate and comfortable
setting. BRCC’s model of integrated community-based care maximizes patient and
family convenience, while offering patients comprehensive care close to home.
Blue
Ridge Cancer Care is united in healing with The US Oncology Network, one of the nation’s largest networks
of integrated community-based oncology practices dedicated to advancing
high-quality, evidence-based cancer care. As an affiliate of The US Oncology
Network, BRCC is united with nearly 1,000 physicians nationwide. Blue Ridge
Cancer Care participates in clinical trials through US Oncology Research, which has played a
role in 48 FDA-approved cancer therapies, nearly one-third of all cancer
therapies approved by the FDA to date. For more information, visit www.usoncology.com.
PR Contact
Contact Public Relations